ARK Investment Management - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 31 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2019$105,000
-68.8%
144,414
+86.7%
0.00%
-75.0%
Q2 2019$336,000
-17.8%
77,348
+38.5%
0.01%
-33.3%
Q1 2019$409,000
-43.7%
55,838
-42.1%
0.01%
-60.0%
Q4 2018$727,000
+19.4%
96,370
-10.6%
0.03%
+66.7%
Q3 2018$609,000107,7610.02%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q3 2018
NameSharesValueWeighting ↓
Prosight Management, LP 1,337,191$7,555,0004.21%
DAFNA Capital Management LLC 537,000$3,034,0001.25%
MEITAV INVESTMENT HOUSE LTD 2,867,047$15,073,0000.74%
SECTORAL ASSET MANAGEMENT INC 1,176,775$6,649,0000.71%
Avoro Capital Advisors LLC 2,570,705$14,524,0000.67%
KNOTT DAVID M 283,473$1,602,0000.52%
CAXTON CORP 64,396$364,0000.34%
Harel Insurance Investments & Financial Services Ltd. 658,835$3,722,0000.18%
Migdal Insurance & Financial Holdings Ltd. 589,996$3,333,0000.07%
683 Capital Management, LLC 150,000$848,0000.06%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders